Medical marijuana and cannabidiol (CBD) are getting a lot of media coverage — so what’s the latest, as it relates to lung cancer? See two recent high-profile articles that weigh the possible risks and benefits of cannabis for cancer and respiratory disease. And add your perspective. (Psst, checkout past PatientsLikeMe write-ups on medical marijuana and CBD for some background.)… Continue reading Marijuana/lung cancer: New reporting on potential risks/benefits of cannabis
Tag: drug research
Can ketamine help when antidepressants don’t? A closer look at the off-label drug that’s in the spotlight
You may have seen ketamine making headlines recently as a promising drug therapy for treatment-resistant depression, or “TRD.” (What’s TRD? Health care professionals define it as receiving at least two different antidepressants– for at least six weeks in a row, and at an adequate dosage – but experiencing less than a 50% improvement in depressive symptoms.) So,… Continue reading Can ketamine help when antidepressants don’t? A closer look at the off-label drug that’s in the spotlight
MS research: What’s the latest?
Keeping tabs on the latest MS research isn’t always easy. So, our team of in-house health professionals took a closer look into some of the treatments in the research pipeline for people living with MS. Most of these treatments are in the final phase of clinical development — phase III clinical trials. In this phase,… Continue reading MS research: What’s the latest?